Ujjivan Financial Services Ltd IPO Message Board (Page 61)

Rajeev thx for ur good suggestions ...can I trust on suzlon..? Wht ur target of dis?

Yes Tushar. U can trust Suzlon. I recommended it when it was hovering at 12. To make matters more clear keep 12 as ur stop loss. Suzy in present condition is not expected to fall below 13.5. However, if it dips then blindly buy. Suzy is a turnaround story and would be in black this or the next quarter. If u hold for 5 yrs to 10 yrs then expect a huge windfall. Its like eicher now. Eicher struggled for profits and valuations for good about seven yrs from 2000 to 2007 but once it started shooting there was no looking back. Many people would be apprehensive of it but remember what Warren Buffet said. Buy when there is panic in market. So trust suzlon. N buy. N hold for long long term. Its the future.

Many many happy returns of the day Eagleye !!!

Dear Moderator,

Please update company''s financial details for Thyrocare and Ujjivan.

Happy B''day dear eagle eye . Wish you a bright future .

Thank you Sir.

Ujjivan GMP 41.50 - 42.50

Dear Eagleye Happy Birthday and we pray to god that WE as a this foram will get his inputs for new IPO forever in future life.God bless her.

Thankyou Sir.

Happy birthday egalgy.

thx

Happy brday eagleye g

Thx Bhupenderbhai.

HAPPY BIRTHDAY EAGLEYE

rajiv kumar sir now which shares u think will go up ?

I m neutral on this ipo. As I skipped Equitas I may not apply in Ujjivan considering my fate against MFIs. However, I Congratulate others those who made Money.

As said earlier I do not like micro financing company model. It may be profitable but would lead to blood on its hands due to suicides of small middle class/ poor people. Would avoid this IPO. Even If one compare Equitas with Ujjivan will find Equitas asset quality better that of Ujjivan. Equitas has exposure in SME etc. Whereas Ujjivan are more prone to risk.
Investors may wait for Final Figure and book profit in short run.

Like u r point (blood on it''s hands)

Pls suggest some company''s name for investment and will give good return which is not engaged with sin

Tnx in advance

rajiv kumar singh sir all housing finance co as suggested by u went up many thanks

Ujjivan eps is 19 Fy 16 they asking 13-14 X which is far better then what Equitas is trading at.

fair value 257

after reading all these(some of) messages, i think Ujjivan goes 300+ most probably in a week after it listed in BSE or NSE and book a profit and exit from Ujjivan. as no one can predict future market and calculation. please confirm.
Thanks,
Mahi

Can someone help me to calculate what should be the Ujjivan valuation relative to Equitas ?

Data given as:

Equitas Holdings
NAV (post IPO) = 58.56 & NAV FY17 = 65.54

@138 (CMP)
P/Bv (post IPO) = 2.36 & P/Bv FY17 = 2.11






Ujjivan Financial Services
NAV (post IPO) = 128.63 & NAV FY17 = 142.75

@210 (Issue Price)
P/Bv (post IPO) = 1.63 & P/Bv FY17 = 1.47

Many happy return of the day
May Each candle on u r cake will brings wonderful surprise for u

Enjoy:)

Thank you Haar Jeet Sir for your kind wishes

Septa g plz suggest me should i buy pankaj piyush or not,plz reply sir

Ujjivan 1000/ Thytocare 1100 - Ahmedabad

what is this figure means? ipo prices are something else?

I want to buy UFL at current GMP . How to buy whom to contact

Thx gravita ....wht ab s H kelkar n quick heal n alkem ?

Not following QH as I was very bearish from start. So, exit is the only option IMO.

Other boarders might have some views on ''when to exit''.

Tushar SH Kelkar results should be seen this quarter before anything is said. However, alkem is a buy n Quick heal is a buy below 225 if it ever comes back to it. Hold all three for min 1 yr to gain.

p/bv is 1.63 at upperband of rs 210 while equitas p/bv is 2.33 at rs 140
if we simply apply ujivan price shoud be 128.63 book value*2.33 =300 rs on listing

Equitas Holdings
NAV (post IPO) = 58.56 & NAV FY17 = 65.54

@138 (CMP)
P/Bv (post IPO) = 2.36 & P/Bv FY17 = 2.11






Ujjivan Financial Services
NAV (post IPO) = 128.63 & NAV FY17 = 142.75

@210 (Issue Price)
P/Bv (post IPO) = 1.63 & P/Bv FY17 = 1.47

Jayeshbhai,

Please help me to calculate the valuation of Thyrocare relative to Dr. Lal ...

Data given as:

THYROCARE TECHNOLOGIES LIMITED
(Refer Page Nos. 101 & 102 of RHP dated 11th Apr’16)

Restated Consolidated Financial Statements:

Diluted EPS
Year Ended March 31, 2015 is Rs.8.98
9 Months ended December 31, 2015 is Rs.7.88 (not annualised)

Return on Net Worth
Year Ended March 31, 2015 is 16.20%
9 Months ended December 31, 2015 is 10.89% (not annualised)

Net Asset Value
Year Ended March 31, 2015 is Rs.54.26
9 Months ended December 31, 2015 is Rs.68.39


DR. LAL PATHLABS LIMITED
(Refer Page Nos. 99 & 100 of RHP dated 27th Nov’15)

Restated Consolidated Financial Statements:

Diluted EPS
Year Ended March 31, 2015 is Rs.11.48
6 Months ended September 30, 2015 is Rs.4.47 (not annualised)

Return on Net Worth
Year Ended March 31, 2015 is 27.85%
6 Months ended September 30, 2015 is 9.16% (not annualised)

Net Asset Value
Year Ended March 31, 2015 is Rs.57.56
6 Months ended September 30, 2015 is Rs.61.78

Dr. Lal CMP = 975